Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Guidance Raises Prospect Of More INDs For Supplement Research

Jan 17 2011

• By Dan Schiff

Related Content

Technical Hurdles, Commercial Limits Complicate Supplement-To-Drug Moves

Jun 28 2010

FDA Clear On Supplement Ingredient Petitions, But Still Fuzzy On Sec. 912

Aug 02 2010

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window